and solid tumor treatment using Roche's patented technology, and is responsible for product development, manufacturing and commercialization , the specific transaction amount was not disclosed .
New Zealand's pioneering cell health brand MitoQ innovates scientific videos to unlock new health
Time of Update: 2022-05-24
and technology to help delay aging, and emphasizes that everyone's health is closely related to cellular health . Cells are the smallest unit of life, and mitochondria provide energy for cells
Novartis Votrient safe and effective for patients with metastatic renal cell carcinoma!
Time of Update: 2022-05-24
>. The drug was approved for marketing in the United States and the European Union in October 2009 and June 2010, respectively . Votrient was originally a product
with chemotherapy significantly improved event-free survival in patients with non-small cell lung cancer
Time of Update: 2022-05-23
CheckMate -816 is the first phase III clinical study to demonstrate that an immune-based combination therapy can significantly improve EFS and pathological complete response (pCR) rates in patients with non-small cell lung cancer in the neoadjuvant phase .
Sci Adv: Scientists hope to develop novel therapy for small cell lung cancer
Time of Update: 2022-05-23
of the EP300 KIX domain in the treatment of novel therapeutic interventions . (Bioon. com)>Original source:>KEE-BEOM KIM, ASHISH
with chemotherapy for the neoadjuvant treatment of selected adult patients with resectable non-small cell lung cancer
Time of Update: 2022-05-23
immune-mediated adverse reactions, including pneumonitis, colitis, hepatitis or hepatotoxicity, endocrinopathy, cutaneous adverse reactions, nephritis with renal insufficiency, and other immune-mediated adverse reactions adverse reactions; infusion
Aging Cell: Scientists Reveal Perredoxin 3 Can Clear Mitochondrial Hydrogen Peroxide To Treat Muscle Atrophy
Time of Update: 2022-05-23
13569Recently, researchers from the Oklahoma Medical Research Foundation published a paper entitled "Scavenging mitochondrial hydrogen peroxide by peroxiredoxin 3 overexpression attenuates contractile dysfunction and muscle atrophy in a murine model of accelerated sarcopenia" in the journal "Aging Cell".
Nat Genet: Delaying DNA replication fork speeds leads to cell fate changes and enhances cell reprogramming efficiency
Time of Update: 2022-05-23
The relevant research results were published online in the journal Nature Genetics on March 7, 2022, with the title of "DNA replication fork speed underlies cell fate changes and promotes reprogramming" .
Cell and gene therapy represented by CAR-T therapy has become a prairie prairie
Time of Update: 2022-05-23
? Standardized development stage (2016-present) In 2017, the State Food and Drug Administration promulgated the "Technical Guidelines for Research and Evaluation of Cell Therapy Products (Trial)", which proposed the safety, Valid, quality-controllable general technical requirements .
Grid cell networks are impaired in a mouse model of early Alzheimer's disease
Time of Update: 2022-05-23
In a J20 transgenic mouse model of familial AD, coding impairment of the MEC grid cell network that overexpresses aβ in the hippocampus and entorhinal cortex .
Nat Aging: Cell regeneration therapy can safely reverse aging in mice
Time of Update: 2022-05-23
"We are delighted that we can use this approach to slow aging in normal animals throughout the lifespan," said co-corresponding author Professor Juan Carlos Izpisua Belmonte of the Gene Expression Laboratory at the Salk Institute for Biological Studies .
Tumours are full of tricks, but bypass the sniper immune cell combination therapy to kill the tumor with a two-pronged approach
Time of Update: 2022-05-22
In a mouse model of ovarian cancer, the researchers used both EPA and purinoceptor antagonists, and the results greatly increased the proliferation of T cells, restoring their ability to kill tumors .
Leukemia: Efficacy and Safety of Guadecitabine in Patients with Peripheral T-Cell Lymphoma
Time of Update: 2022-05-22
RHOAG17V mutation is associated with prolonged progression-free survivalIn conclusion, Guadecitabine demonstrated acceptable overall response rates and toxicity profiles in patients with peripheral T-cell lymphoma ; decitabine analogs may be promising candidates for future combined targeting of histone methyltransferases.
BeiGene's Tislelizumab Approved for the Eighth Indication for Esophageal Squamous Cell Carcinoma
Time of Update: 2022-05-22
Screenshot source: NMPA official websiteTislelizumab is a humanized IgG4 anti-programmed death 1 (PD-1) monoclonal antibody designed to minimize binding to Fcγ receptors in macrophages .
New research in the sub-journal of Nature reveals the regulatory mechanism of hematopoietic stem cells entering the bone marrow for the first time
Time of Update: 2022-05-22
▲The huge difference between hematopoietic stem cells and bone marrow microenvironment between embryonic and adulthood (Image source: Reference [1])The experimental results revealed that the bone artery is the key microenvironmental cell in the embryonic stage .
"Cell" important breakthrough!
Time of Update: 2022-05-22
ways, and can even transmit specific signals to the brain through the gastrointestinal vagus nerve . In the field of oncology, microorganisms are also one of the objects that scientists focus
J Clin Oncol: Efficacy and safety of nasoprilumab in the treatment of hematopoietic stem cell transplantation-associated thrombotic microangiopathy
Time of Update: 2022-05-21
This study is a single-arm, open-label, flight trial to evaluate the safety and efficacy of nasoprilumab in adult patients with HSCT-TMA .
Cell: Heavy!
Time of Update: 2022-05-21
ovarian cancer"These smart cell therapies can deliver powerful therapeutic activity precisely at the site of disease, improving efficacy and reducing the chance of life-threatening toxicity in patients," Roybal said .
